Jesper B. Andersen
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, MicroRNA in disease regulation, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Cholangiocarcinoma 2020: the next horizon in mechanisms and management(2020)2,374 cited
- → Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)(2016)1,366 cited
- → Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties(2009)729 cited
- → Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles(2017)605 cited
- → Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors(2011)548 cited
- → Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma(2017)469 cited
- → Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients(2013)441 cited
- → Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas(2012)383 cited
- → Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry(2022)328 cited
- → Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer(2015)317 cited